Literature DB >> 10685599

The third tubulin pool.

L Lafanechère1, D Job.   

Abstract

Tubulin normally undergoes a cycle of detyrosination/tyrosination on the carboxy terminus of its alpha-subunit and this results in subpopulations of tyrosinated tubulin and detyrosinated tubulin. Brain tubulin preparations also contain a third major tubulin subpopulation which is non-tyrosinatable. This review describes the purification and the structural characterization of non-tyrosinatable tubulin. This tubulin variant lacks a carboxyterminal glutamyl-tyrosine group on its alpha-subunit (delta2-tubulin). Delta2-tubulin is generated from detyrosinated tubulin through an irreversible reaction. Delta2-tubulin accumulates in neurons and in stable microtubule assemblies. It also accumulates in some tumor cells due to the frequent loss of tubulin tyrosine ligase in such cells. Delta2-tubulin may be a useful marker of malignancy in human tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10685599     DOI: 10.1023/a:1007575012904

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  73 in total

1.  Simian virus 40 large T antigen and p53 are microtubule-associated proteins in transformed cells.

Authors:  S A Maxwell; S K Ames; E T Sawai; G L Decker; R G Cook; J S Butel
Journal:  Cell Growth Differ       Date:  1991-02

Review 2.  Posttranslational tyrosination/detyrosination of tubulin.

Authors:  H S Barra; C A Arce; C E Argaraña
Journal:  Mol Neurobiol       Date:  1988       Impact factor: 5.590

3.  Uncorporation of phenylalanine as a single unit into rat brain protein: reciprocal inhibition by phenylalanine and tyrosine of their respective incorporations.

Authors:  H S Barra; C A Arcce; J A Rodriguez; R Caputto
Journal:  J Neurochem       Date:  1973-11       Impact factor: 5.372

4.  Preferential action of a brain detyrosinolating carboxypeptidase on polymerized tubulin.

Authors:  N Kumar; M Flavin
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

5.  Tubulin-tyrosine ligase from brain.

Authors:  M Flavin; T Kobayashi; T M Martensen
Journal:  Methods Cell Biol       Date:  1982       Impact factor: 1.441

6.  The cyclic tyrosination/detyrosination of alpha tubulin.

Authors:  W C Thompson
Journal:  Methods Cell Biol       Date:  1982       Impact factor: 1.441

7.  Cloning, expression, and properties of the microtubule-stabilizing protein STOP.

Authors:  C Bosc; J D Cronk; F Pirollet; D M Watterson; J Haiech; D Job; R L Margolis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

8.  Turnover of the carboxy-terminal tyrosine of alpha-tubulin and means of reaching elevated levels of detyrosination in living cells.

Authors:  J Wehland; K Weber
Journal:  J Cell Sci       Date:  1987-09       Impact factor: 5.285

9.  Accumulation of delta 2-tubulin, a major tubulin variant that cannot be tyrosinated, in neuronal tissues and in stable microtubule assemblies.

Authors:  L Paturle-Lafanechère; M Manier; N Trigault; F Pirollet; H Mazarguil; D Job
Journal:  J Cell Sci       Date:  1994-06       Impact factor: 5.285

10.  Detyrosination of alpha tubulin does not stabilize microtubules in vivo.

Authors:  D R Webster; J Wehland; K Weber; G G Borisy
Journal:  J Cell Biol       Date:  1990-07       Impact factor: 10.539

View more
  16 in total

Review 1.  Post-translational modifications of microtubules.

Authors:  Dorota Wloga; Jacek Gaertig
Journal:  J Cell Sci       Date:  2010-10-15       Impact factor: 5.285

2.  The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway.

Authors:  Roy Barco; Laura B Hunt; Andrea L Frump; Christina B Garcia; Andrew Benesh; Robert L Caldwell; Josiane E Eid
Journal:  Mol Biol Cell       Date:  2007-08-08       Impact factor: 4.138

Review 3.  Lysine post-translational modifications and the cytoskeleton.

Authors:  Wendy D Zencheck; Hui Xiao; Louis M Weiss
Journal:  Essays Biochem       Date:  2012       Impact factor: 8.000

Review 4.  Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.

Authors:  Vivek Bhakta Mathema; Young-Sang Koh; Balkrishna Chand Thakuri; Mika Sillanpää
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

Review 5.  Post-translational modifications of tubulin: pathways to functional diversity of microtubules.

Authors:  Yuyu Song; Scott T Brady
Journal:  Trends Cell Biol       Date:  2014-11-25       Impact factor: 20.808

6.  Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle.

Authors:  Ziad J Sahab; Michael D Hall; You Me Sung; Sivanesan Dakshanamurthy; Yun Ji; Deepak Kumar; Stephen W Byers
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

7.  Azaindole derivatives are inhibitors of microtubule dynamics, with anti-cancer and anti-angiogenic activities.

Authors:  Renaud Prudent; Émilie Vassal-Stermann; Chi-Hung Nguyen; Marjorie Mollaret; Jean Viallet; Agnès Desroches-Castan; Anne Martinez; Caroline Barette; Catherine Pillet; Glaucio Valdameri; Emmanuelle Soleilhac; Attilio Di Pietro; Jean-Jacques Feige; Marc Billaud; Jean-Claude Florent; Laurence Lafanechère
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 8.  Tubulin proteomics: towards breaking the code.

Authors:  Pascal Verdier-Pinard; Eddy Pasquier; Hui Xiao; Berta Burd; Claude Villard; Daniel Lafitte; Leah M Miller; Ruth H Angeletti; Susan Band Horwitz; Diane Braguer
Journal:  Anal Biochem       Date:  2008-09-18       Impact factor: 3.365

9.  Characterization of sub-nuclear changes in Caenorhabditis elegans embryos exposed to brief, intermediate and long-term anoxia to analyze anoxia-induced cell cycle arrest.

Authors:  Vinita A Hajeri; Jesus Trejo; Pamela A Padilla
Journal:  BMC Cell Biol       Date:  2005-12-20       Impact factor: 4.241

10.  Evidence for new C-terminally truncated variants of α- and β-tubulins.

Authors:  Chrystelle Aillaud; Christophe Bosc; Yasmina Saoudi; Eric Denarier; Leticia Peris; Laila Sago; Nicolas Taulet; Adeline Cieren; Olivia Tort; Maria M Magiera; Carsten Janke; Virginie Redeker; Annie Andrieux; Marie-Jo Moutin
Journal:  Mol Biol Cell       Date:  2016-01-06       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.